AMST News

The US IPO market seems to be hitting the pause button to recognize the holidays, with no companies on the calendar to price in the coming week. However, there is still a possibility that certain SPACs or Chinese deals launch early in the week to price by Christmas Eve. Though launches and pricings may take a brief respite, we will be on the lookout for filings over the holiday...read more

September activity remained high as 11 IPOs and eight SPACs went public this past week. The IPO market shows no signs of slowing with eight IPOs and 18 SPACS submitting initial filings. Prescription drug price comparison platform GoodRx (GDRX) priced well above the range to raise $1.1 billion at a $14.2 billion market cap. The company provides one of the...read more

Amesite, which provides an AI-driven platform for developing online learning products, raised $15 million by offering 3 million shares at $5, within the range of $4.50 to $5.50. The company offered 0.1 million fewer shares than anticipated. Amesite plans to list on the Nasdaq under the symbol AMST. Laidlaw & Company (UK) acted as a lead manager on the deal. ...read more

In another busy week for the September IPO market, eight IPOs are scheduled to raise $2.0 billion, led by prescription drug marketplace GoodRx Holdings (GDRX).  The largest deal of the week, GoodRx (GDRX) plans to raise $900 million at an $11.2 billion market cap. The company operates in the large prescription drug...read more